Literature DB >> 11145257

Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-cell gastric lymphomas.

A J Ferreri1, M Freschi, S Dell'Oro, E Viale, E Villa, M Ponzoni.   

Abstract

The prognostic value of histopathologic features was assessed in 83 patients with stage I-II gastric B-cell lymphomas (PGL). The following histotypes were considered: low-grade mucosa-associated lymphoid tissue (MALT)-type lymphoma (LGML; n = 35), diffuse large B-cell lymphoma with areas of MALT-type lymphoma (DLCLML; n = 20) and diffuse large B-cell lymphoma without areas of MALT-type lymphoma (DLCL; n = 28). Low-grade (LG) and high-grade (HG) components, lymphoepithelial lesions (LEL), size of cells giving rise to LEL, and amount and growth pattern of large cells (LC) were analyzed. Five-year cause-specific survival (CSS) for patients with LGML, DLCLML, and DLCL were 94%, 84%, and 64%, respectively (p = 0.05). LG component or LEL were associated with a significantly longer 5-year CSS, whereas the presence of an HG component, defined as clustered LC greater than 10% of neoplastic population, was significantly related to a shorter survival. Lymphomas with LC disposed in clusters were associated with a worse survival in comparison with cases with scattered LC. The presence of scattered LC 5%-10% appeared irrelevant in LGML. When analysis was limited to DLCLML/ DLCL patients, the presence of LG component or LEL was associated with a significantly longer 5-year CSS, whereas the existence of LEL formed by LC (HG LEL) did not modify survival. Multivariate analysis, adjusted by the main prognostic factors, confirmed the independent and significant association between histopathologic categorization and survival. Age, stage, lactate dehydrogenase (LDH) ratio, thrombocytopenia, and use of chemotherapy had independent prognostic value. In conclusion, histopathologic categorization is an independent prognosticator in PGL. The formation of compact clusters by LC, rather than their amount, is a true prognostic variable. The presence of scattered LC 5%-10% appears irrelevant in LGML. LG component and LEL are favorable predictors in HG lymphomas, helping to identify two subsets of DLCL with different prognosis.

Entities:  

Mesh:

Year:  2001        PMID: 11145257     DOI: 10.1097/00000478-200101000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  17 in total

1.  Distinction between "high grade MALT" and diffuse large B cell lymphoma. Mucosa associated lymphoid tissue.

Authors:  S Ely
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

Review 2.  Nodal aggressive B-cell lymphomas: a diagnostic approach.

Authors:  Sonam Prakash; Steven H Swerdlow
Journal:  J Clin Pathol       Date:  2007-03-16       Impact factor: 3.411

Review 3.  Clonal relationship of marginal zone lymphoma and diffuse large B-cell lymphoma in Sjogren's syndrome patients: case series study and review of the literature.

Authors:  Vadim Romanovich Gorodetskiy; Natalya Alexandrovna Probatova; Stefka Gospodinova Radenska-Lopovok; Natalya Valerievna Ryzhikova; Yulia Vladimirovna Sidorova; Andrey Borisovich Sudarikov
Journal:  Rheumatol Int       Date:  2019-11-09       Impact factor: 2.631

4.  [Extranodal marginal zone B-cell lymphoma of MALT-type].

Authors:  P Adam; E Haralambieva; G Ott
Journal:  Pathologe       Date:  2007-02       Impact factor: 1.011

5.  Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.

Authors:  Linzhu Zhai; Yuanyuan Zhao; Sheng Ye; He Huang; Ying Tian; Qiuliang Wu; Hanliang Lin; Tongyu Lin
Journal:  Tumour Biol       Date:  2011-06-10

6.  A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours.

Authors:  R Ranaldi; G Goteri; M G Baccarini; B Mannello; I Bearzi
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

Review 7.  Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists.

Authors:  Chris M Bacon; Ming-Qing Du; Ahmet Dogan
Journal:  J Clin Pathol       Date:  2006-09-01       Impact factor: 3.411

Review 8.  De-escalating therapy in gastric aggressive lymphoma.

Authors:  Rosanna Cuccurullo; Silvia Govi; Andrés J M Ferreri
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 9.  Therapy of gastric mucosa associated lymphoid tissue lymphoma.

Authors:  Andrea Morgner; Renate Schmelz; Christian Thiede; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

10.  Primary prostatic lymphoma with components of both diffuse large B-cell lymphoma (DLBCL) and MALT lymphoma.

Authors:  G Petrakis; T Koletsa; V Karavasilis; G Rallis; M Bobos; G Karkavelas; I Kostopoulos
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.